²é¿´: 1153  |  »Ø¸´: 1

ʯ¿âÃÅ

гæ (³õÈëÎÄ̳)

[½»Á÷] ÀîºìÁ¼½ÌÊÚ¡¶È¥·ºËØ»¯Ã¸TNFAIP3ͨ¹ýÒÖÖƸÎÔàASK1»îÐÔ»º½â·Ç¾Æ¾«ÐÔÖ¬·¾¸ÎÑס·

¹úÊÇÊÀ½ç¸Î²¡´ó¹ú£¬È«¹ú³¬¹ý3ÒÚÈË´æÔÚ²»Í¬³Ì¶ÈµÄ·Ç¾Æ¾«ÐÔÖ¬·¾¸Î£¬¿É½øÒ»²½·¢Õ¹Îª¸ÎÓ²»¯£¬ÉõÖÁ¸Î°©¡¢¸ÎË¥½ß£¬Í¬Ê±Ôö¼Ó¶àÖÖÐÄÄÔѪ¹ÜºÍ´úлÐÔ¼²²¡»¼²¡·çÏÕ¡£È»¶ø£¬¹ú¼ÊÉÏÉÐÎÞÕë¶Ô·Ç¾Æ¾«ÐÔÖ¬·¾¸ÎµÄÁÙ´²ÓÃÒ©¡£¸ÎÔàÇгýºÍ¸ÎÔàÒÆÖ²³ÉΪÖÎÁÆÍíÆڸβ¡µÄÖ÷ÒªÊֶΣ¬µ«ÊÖÊõ¹ý³ÌÖв»¿É±ÜÃâµÄ¸ÎÔàȱѪÔÙ¹à×¢ËðÉ˼«´óÏÞÖÆÁ˸ÎÔàÊÖÊõµÄ¿ªÕ¹ºÍ¾ÈÖÎЧ¹û¡£

±¾´Î·¢±íµÄÁ½ÆªÂÛÎÄÖУ¬¡°The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis¡±£¨¡¶È¥·ºËØ»¯Ã¸TNFAIP3ͨ¹ýÒÖÖƸÎÔàASK1»îÐÔ»º½â·Ç¾Æ¾«ÐÔÖ¬·¾¸ÎÑס·£©²ûÊÍÁËÒ»ÌõеķǾƾ«ÐÔÖ¬·¾¸Î²¡·¢Õ¹ÄÚÔÚµÄÒÖÖÆ;¾¶¡£²©Ê¿ºóÕÅÅô¡¢ÍõاÏþ¡¢²©Ê¿ÉúÕÔÁáƼΪ¹²Í¬µÚÒ»×÷Õߣ¬ÀîºìÁ¼ºÍÕÛÖ¾¸Õ½ÌÊÚΪ¹²Í¬Í¨Ñ¶×÷Õß¡££¨ÂÛÎÄÁ´½Ó£ºhttps://www.nature.com/articles/nm.4453£©

Activation of apoptosis signal-regulating kinase 1 (ASK1) in hepatocytes is a key process in the progression of nonalcoholic steatohepatitis (NASH) and a promising target for treatment of the condition. However, the mechanism underlying ASK1 activation is still unclear, and thus the endogenous regulators of this kinase remain open to be exploited as potential therapeutic targets. In screening for proteins that interact with ASK1 in the context of NASH, we identified the deubiquitinase tumor necrosis factor alpha¨Cinduced protein 3 (TNFAIP3) as a key endogenous suppressor of ASK1 activation, and we found that TNFAIP3 directly interacts with and deubiquitinates ASK1 in hepatocytes. Hepatocyte-specific ablation of Tnfaip3 exacerbated nonalcoholic fatty liver disease¨C and NASH-related phenotypes in mice, including glucose metabolism disorders, lipid accumulation and enhanced inflammation, in an ASK1-dependent manner. In contrast, transgenic or adeno-associated virus¨Cmediated TNFAIP3 gene delivery in the liver in both mouse and nonhuman primate models of NASH substantially blocked the onset and progression of the disease. These results implicate TNFAIP3 as a functionally important endogenous suppressor of ASK1 hyperactivation in the pathogenesis of NASH and identify it as a potential new molecular target for NASH therapy.
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ʯ¿âÃÅ

гæ (³õÈëÎÄ̳)

The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis
Peng Zhang, Pi-Xiao Wang, Ling-Ping Zhao, Xin Zhang, Yan-Xiao Ji, Xiao-Jing Zhang, Chun Fang, Yue-Xin Lu, Xia Yang, Mao-Mao Gao, Yan Zhang, Song Tian, Xue-Yong Zhu, Jun Gong, Xin-Liang Ma, Feng Li, Zhihua Wang, Zan Huang, Zhi-Gang She & Hongliang Li
2Â¥2018-07-17 21:51:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌøת ÎÒÒª¶©ÔÄÂ¥Ö÷ ʯ¿âÃÅ µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍƼö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[½Ìʦ֮¼Ò] ˵ͬѧ¶Ô´ý±ÏÒµÂÛÎIJ»ÈÏÕæºóËýºÜ²»Ôà +15 ºÓÎ÷Ò¹ÀÉ 2024-04-30 19/950 2024-05-06 15:21 by ϪɽÓοÍ
[½Ìʦ֮¼Ò] Çë½Ìϸ÷룬ÄϾ©º½¿Õº½Ìì´óѧÌìÄ¿ºþУÇøÈçºÎ£¿ +3 pp°®Ð´ÂÛÎÄ 2024-05-05 4/200 2024-05-06 14:59 by eseayl
[Óлú½»Á÷] õ¥»¯ºÍõ¥½»»» 40+4 whw818 2024-05-04 5/250 2024-05-06 14:24 by ÊÀ½çÖ®Ô´
[¿¼²©] »ªÄÏÀí¹¤´óѧÅíÐÂÎĽÌÊÚ¿ÎÌâ×éÕÐƸ²©Ê¿Ñо¿Éú1Ãû£¨2024Äê9Ô·ÝÈëѧ£© +4 ²»³Ôô~µÄ؈ 2024-05-04 4/200 2024-05-06 13:06 by û²©¶ÁµÄº¢×Ó
[»ù½ðÉêÇë] »ù½ðº¯ÆÀ¿ªÊ¼ÁËÂð +5 fuzy 2024-05-05 5/250 2024-05-06 11:57 by hdzw9071
[¿¼ÑÐ] Òª²»Òª¶þÕ½£¿ +6 ajjznskk 2024-05-05 9/450 2024-05-06 11:36 by ¿¨Æ¤°ÉÀ²123
[½Ìʦ֮¼Ò] У¼¶ÓÅÐã±¾¿Æ±ÏÒµÂÛÎÄ£¬±ÈÀý¶àÉÙ£¿¿´Ö¸µ¼½Ìʦ×ÊÀúÂ𣿠+7 ºÓÎ÷Ò¹ÀÉ 2024-05-04 10/500 2024-05-06 11:33 by huaxuejidi
[»ù½ðÉêÇë] ¶à´óËã´óÁ䣿 +5 wyjecho666 2024-05-01 6/300 2024-05-06 11:06 by ÃÎÏë³ÉÕæ2014
[»ù½ðÉêÇë] ÌØƸ½ÌÊÚ£¬Ëã¸ß¼¶Ö°³ÆÂð£¿ÇàÄê»ù½ð»¹Ã»½áÌâµÄÇé¿öÏ»¹Äܱ¨ÃæÉÏÂ𣿠+9 aasahr 2024-05-05 10/500 2024-05-06 10:43 by zwdct
[¿¼²©] ʳƷרҵѰ²©Ê¿µ¼Ê¦ +4 ÀïÊÏʲôÀâ 2024-04-29 9/450 2024-05-06 10:31 by ÍêÃÀÊÀ½ç»ÄÌìµÛ
[½Ìʦ֮¼Ò] ²©Ê¿±ÏÒµÕÒ¹¤×÷Ñ¡Ôñ£¡ +10 gsqºÙºÙ 2024-04-30 14/700 2024-05-06 09:44 by meier8
[ÂÛÎÄͶ¸å] Optics ExpressÒ»Ö±¿¨ÔÚFinal Decision +3 MissPro 2024-05-05 7/350 2024-05-06 08:44 by MissPro
[¸ß·Ö×Ó] ÇóÍƼöÑо¿U VÈÈÈÛ½ºµÄ¸ßÊÖ +3 ǧÄêÒ»³æ 2024-05-04 3/150 2024-05-06 08:13 by jiduquegai
[ÂÛÎÄͶ¸å] ÏëÇëÎÊÏÂIEEE Trans×îºóÒ»ÂÖ£¬ÄãÃǵÈÁ˶à¾Ã£¿ +4 DD4Dr 2024-05-03 7/350 2024-05-05 16:14 by topedit
[Óлú½»Á÷] DMFÔõô³ýË® +7 °®³ÔÏã²ËµÄС»Æ¹ 2024-05-01 12/600 2024-05-05 10:53 by ppttjjboy
[ÂÛÎÄͶ¸å] ÏëÎÊϵç³Ø·¢ÔÚnano lettersº¬½ðÁ¿¸ß²»¸ß +6 δÀ´¸»ÆÅÍÜ 2024-04-30 11/550 2024-05-05 10:53 by eemdl
[ÂÛÎÄͶ¸å] Ͷ¸åijһSCIÆÚ¿¯£¬ÂÛÎı»¾Ü¾ø£¬ÊÇ·ñ¿ÉÒÔÔÙ´ÎͶ¸åµ½Õâ¸öÆÚ¿¯£¿ 4+3 ilyzm 2024-05-03 7/350 2024-05-05 09:20 by bobvan
[¿¼²©] ±±¾©Ê¦·¶´óѧÈ˹¤ÖÇÄÜѧԺ2024ÄêµÚ¶þÅú²©Ê¿Ñо¿ÉúÕÐÉú±¨Ãû +4 taoto 2024-05-02 5/250 2024-05-04 15:46 by LYS1200
[˶²©¼ÒÔ°] È¥ÃÀ¹úµÄ»ªÈ˵¼Ê¦µ×϶Á²©ºó»áºÜÄѳöÕ¾Â𣿠+6 Aries-FZU 2024-05-03 6/300 2024-05-04 07:32 by ÏþÄ¿³ç
[ÂÛÎÄͶ¸å] µÚһƪÂÛÎÄÖÕÓÚ½øÈ¥Éó¸å״̬ÁË +5 lizhengke06 2024-05-01 8/400 2024-05-03 09:14 by nono2009
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û